Barbara Rizzardi

TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study

Ciarán P. Kelly, Joseph A. Murray, Daniel A. Leffler et al. · Gastroenterology · 2021 · 167 citations · Full text

Food Intolerance, Autoimmune Disease, Allergy +6

Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age

Evan J. Anderson, C. Buddy Creech, Vladimir Berthaud et al. · New England Journal of Medicine · 2022 · 136 citations · Full text

Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial

Timo Vesikari, Joanne M. Langley, Nathan Segall et al. · The Lancet Infectious Diseases · 2021 · 70 citations

Vaccination, Vaccine Safety, Viral Hepatitis +8

Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus–diphtheria–acellular pertussis vaccine: a randomised, double-blind, phase 2b trial

Cheryl Keech, Vicki E. Miller, Barbara Rizzardi et al. · The Lancet · 2023 · 54 citations

Vaccinology, Vaccine Safety, Vaccination +8

Long-term efficacy and immunogenicity of Ad26.RSV.preF–RSV preF protein vaccine (CYPRESS): a randomised, double-blind, placebo-controlled, phase 2b study

Ann R. Falsey, Tessa Hosman, Arangassery Rosemary Bastian et al. · The Lancet Infectious Diseases · 2024 · 23 citations

Vaccinology, Vaccination, Vaccine Development +7